Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,837 total articles

All In FutureTech Alliance Long-Term Strategic Direction Following the HyalRoute Acquisition: Building a Future Technology Platform Driven by AI Infrastructure and AI Applications, with Optical Technologies at Its Core

All In FutureTech Alliance Long-Term Strategic Direction Following the HyalRoute Acquisition: Building a Future Technology Platform Driven by AI Infrastructure and AI Applications, with Optical Technologies at Its Core

All In FutureTech Alliance Inc. (Nasdaq: AGAE) announced its strategic direction following the acquisition of a controlling interest in HyalRoute Fiber-Optic Communication Group, a company owning extensive fiber-optic networks in Southeast Asia and submarine cable assets. The acquisition marks a key milestone in AIFA's transformation from an experi…

European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union

European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union

Pharming Group has secured European Commission marketing authorization for Joenja® (leniolisib), the first approved treatment for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in the EU. This approval expands the drug's global reach, already approved in the US, UK, Japan, Australia, and Israel, with planned European launch start…

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026

Scilex Holding Company, a Nasdaq-listed biopharmaceutical firm specializing in non-opioid pain management products, declared a dividend distribution of Semnur Pharmaceuticals, Inc. common stock to its eligible shareholders as of June 1, 2026. This dividend correlates to one share of Semnur for each Scilex common share held. The move reflects Scilex…

Cuprina Holdings announces 1-for-8 Share Consolidation

Cuprina Holdings announces 1-for-8 Share Consolidation

Cuprina Holdings plans a 1-for-8 share consolidation effective around May 27, 2026, to comply with Nasdaq listing rules and maintain its listing on the Nasdaq Capital Market. The consolidation will convert every eight existing shares into one new share, adjusting the par value accordingly. This move aims to strengthen the company's capital markets …

SemiLux International Ltd. Announces Receipt of Nasdaq Staff Determination Letter and Intention to Request Hearing

SemiLux International Ltd. Announces Receipt of Nasdaq Staff Determination Letter and Intention to Request Hearing

SemiLux International Ltd. received a Nasdaq Staff Determination Letter notifying the company of its pending delisting from The Nasdaq Capital Market due to failure to meet minimum bid price and stockholders' equity requirements and outstanding Form 20-F filings. The company plans to request a hearing and submit a compliance plan to regain listing …

Allsteel Introduces Flourish, A Design-Forward Collaborative Chair

Allsteel Introduces Flourish, A Design-Forward Collaborative Chair

Allsteel, a brand under HNI Corporation, has introduced Flourish, a new collaborative chair designed for evolving work environments emphasizing flexibility and individuality. Featuring a distinctive petaled back and customizable base options, Flourish aims to enhance comfort and design expression in various office spaces. The chair meets rigorous e…

XMax Announces Additional AI Services Agreement Expected to Generate Up to Approximately $3.6 Million in Annual Revenue

XMax Announces Additional AI Services Agreement Expected to Generate Up to Approximately $3.6 Million in Annual Revenue

XMax Inc., through its subsidiary XMax AI Inc., has entered a new AI Model API Services Agreement with a new customer. The contract, estimated to generate up to $3.6 million annually, involves providing cloud-based AI model API services and infrastructure. This agreement highlights growing enterprise demand for scalable AI deployment solutions and …

South Jersey Industries, Inc. Announces Amendment and Extension of Cash Tender Offer for Any and All of the Outstanding 2018 Series A 3.70% Remarketable Junior Subordinated Notes due 2031

South Jersey Industries, Inc. Announces Amendment and Extension of Cash Tender Offer for Any and All of the Outstanding 2018 Series A 3.70% Remarketable Junior Subordinated Notes due 2031

South Jersey Industries, Inc. announced an amendment and extension to its cash tender offer for all outstanding 2018 Series A 3.70% Remarketable Junior Subordinated Notes due 2031, increasing the total consideration from $920 to $955 per $1,000 principal amount and extending the expiration time to May 29, 2026. The offer remains subject to customar…

Futu Receives Investigation Notice and Administrative Penalty Pre-Notification Letter from the China Securities Regulatory Commission

Futu Receives Investigation Notice and Administrative Penalty Pre-Notification Letter from the China Securities Regulatory Commission

Futu Holdings Limited disclosed that it has received a Notice of Investigation and an Administrative Penalty Pre-Notification Letter from the China Securities Regulatory Commission related to unlicensed securities, fund sales, and futures business activities by its mainland China and Hong Kong entities. The CSRC proposes penalties amounting to appr…

BioAge Labs to Present at Upcoming Investor Conferences

BioAge Labs to Present at Upcoming Investor Conferences

BioAge Labs, a clinical-stage biotechnology company focusing on therapies for metabolic diseases through targeting human aging biology, announced participation in upcoming healthcare investor conferences hosted by Jefferies and Goldman Sachs. The company will present updates on its lead candidate BGE-102, a brain-penetrant NLRP3 inhibitor with prom…

Moomoo Expands Crypto Trading to Texas and Launches Direct Crypto Transfers, Advancing Unified Multi-Asset Investing

Moomoo Expands Crypto Trading to Texas and Launches Direct Crypto Transfers, Advancing Unified Multi-Asset Investing

Moomoo Technologies Inc., a Nasdaq-listed global investment and trading platform, announced the expansion of its cryptocurrency trading services to Texas along with the launch of a Direct Crypto Deposit & Withdraw feature for U.S. users. This move broadens crypto accessibility to multiple U.S. states and integrates seamless multi-asset investing by…

Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep’s Potential Across Gastrointestinal Tumors

Oncolytics Biotech® to Present Data at ASCO 2026 Reinforcing Pelareorep’s Potential Across Gastrointestinal Tumors

Oncolytics Biotech Inc. announced that new translational data from its GOBLET and AWARE-1 clinical trials involving pelareorep will be presented at the 2026 ASCO Annual Meeting. The data demonstrates pelareorep's mechanism of activating immune responses in difficult-to-treat cancers with KRAS mutations, specifically pancreatic and breast cancers. T…

20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand

20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand

20/20 Biolabs announces contingency plans to develop Ebola and Hantavirus PCR testing in its CAP-accredited CLIA laboratory to support potential overflow demand from public health laboratories. Drawing on its extensive COVID-19 testing experience, the company is engaging with global PCR test kit developers and evaluating existing equipment for rapi…

FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting

FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting

FibroBiologics, Inc., a clinical-stage biotechnology company, announced preclinical data from its CYPS317 program for psoriasis presented at the Society for Investigative Dermatology 2026 Annual Meeting. The data demonstrated that fibroblast spheroids provided sustained therapeutic benefits and a favorable safety profile in psoriasis mouse models b…

Ebola Outbreak “Spreading at Alarming Speed,” WHO Warns — Growing Global Health Emergencies Highlight Rising Need for TOMI’s SteraMist Technology

Ebola Outbreak “Spreading at Alarming Speed,” WHO Warns — Growing Global Health Emergencies Highlight Rising Need for TOMI’s SteraMist Technology

TOMI Environmental Solutions underscores the urgent need for advanced decontamination technologies as the WHO warns of a rapidly spreading Ebola outbreak in Central Africa involving the dangerous Bundibugyo strain. Leveraging its proven SteraMist system, TOMI positions itself as a key player in infectious disease containment efforts globally, servi…